| Bioactivity | CB-52 is the ligand and neutral antagonist of CB2 cannabinoid receptor[1]. |
| Invitro | CB-52 抑制 Forskolin (HY-15371) 诱导的 N18TG2 细胞 (IC50: 450 nM) 和 hCB1-CHO 细胞 (EC50: 2600 nM) 的 cAMP 形成[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> CB-52 相关抗体: |
| In Vivo | CB-52 (1 和 5 mg/kg，腹腔注射) 可降低大鼠对热刺激的痛阈，并阻断 WIN55,212-2 (2.5 mg/kg，腹腔注射) 引起的抗伤害作用[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
| CAS | 869376-90-9 |
| Formula | C26H43NO3 |
| Molar Mass | 417.62 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Cascio MG, et al. In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands. Br J Pharmacol. 2006 Oct;149(4):431-40. |